Atlanta Capital

CIO Charles Shelton III, President W. Allen Cates, and a centralized investment committee make all buy and sell decisions collectively. The firm has maintained this same leadership group for over two decades. There is no analyst-driven or quantitative screening override; every name in the portfolio must earn unanimous committee approval.

Atlanta Capital operates as a wholly owned, autonomous subsidiary of Eaton Vance, which Morgan Stanley acquired in March 2021. The Morgan Stanley parent provides institutional distribution, compliance infrastructure, and balance sheet support, but the Atlanta-based investment team retains full autonomy over portfolio construction, research, and trading. No Morgan Stanley model portfolio is forced onto the Atlanta Capital strategies.

Portfolios typically hold between 25 and 40 positions, with the top 10 names often comprising more than 40% of total assets. The firm deliberately avoids the diversification-for-its-own-sake approach common among institutional managers. Turnover runs well below 15% in most years, consistent with the stated ten-year minimum holding-period philosophy.

No. The firm exclusively manages publicly traded equity portfolios—large-cap growth, SMID-cap growth, and an all-cap quality-growth mandate. They do not run private equity, venture capital, credit strategies, or hedge fund structures. Allocators seeking alternatives exposure must look elsewhere within or beyond the Morgan Stanley umbrella.

The Calvert Equity Fund (CSIEX), a dedicated quality-growth mutual fund, is the primary commingled access point. The firm also runs the identical strategy through separately managed accounts for institutional investors. There is no ETF wrapper available, consistent with the high-active-share, low-turnover mandate.

Highly leveraged balance sheets, cyclical commodity-exposed businesses, speculative pre-revenue biotech, and any company whose earnings stream cannot be modeled with reasonable confidence five years out. The firm also avoids macro-driven sector rotation; capital is allocated only to individual businesses meeting the absolute quality threshold, never to fill a GICS sector gap.

The all-cap mandate can own any company across the market-cap spectrum that meets the quality-growth criteria, without limit on size or benchmark. This contrasts with the large-cap growth strategy, which stays within roughly the top 1,000 US names, and the SMID-cap strategy, which bounds itself to smaller-capitalization ranges. The investable universe is identical; the difference is purely portfolio construction and client guidelines.